Previous close | 39.89 |
Open | 40.20 |
Bid | 40.13 x 400 |
Ask | 40.16 x 400 |
Day's range | 39.93 - 40.68 |
52-week range | 27.13 - 48.52 |
Volume | |
Avg. volume | 2,176,945 |
Market cap | 14.449B |
Beta (5Y monthly) | 1.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.40 (3.49%) |
Ex-dividend date | 13 May 2024 |
1y target est | N/A |
Heather Adamson, SVP, Marketing, Acentra Health Heather Adamson joins Acentra Health as SVP of Marketing. MCLEAN, Va., June 18, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced that Heather Adamson has joined the company as Senior Vice President of Marketing. In this role, Adamson will oversee the development and implementation of the company’s marke
Multi-phase demonstration is first in the U.S. to introduce Medicaid funding for interventions that address health outcomes related to social needsMCLEAN, Va., June 13, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced it was awarded a contract from the Oregon Health Authority (OHA) to implement a division of the state’s 1115 Health Related Social Nee
Acentra Health Named ‘Corporate Growth Company of the Year’ by ACG National Capital Acentra Health’s CEO, Todd Stottlemyer, and Executive Vice President/Chief Financial Officer, David Adams, accept the award for ACG National Capital’s ‘Corporate Growth Company over $250 million’ on June 6, 2024, in McLean, VA. MCLEAN, Va., June 11, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better he